SEC Form D private-offering filing

NEUROPATHIX, INC.

A new SEC Form D private-offering notice from Doylestown, PA, a $50,000,000 filer-stated offering target in Biotech. The source filing is one click away.

NEUROPATHIX, INC. site↗ Verified via SEC Form D

Biopharmaceutical company developing cannabidiol derived therapeutics for neuroinflammation and neuropathic pain

Filed 2025-11-17Filed to raise $50,000,000HQ (as filed) Doylestown, PASector Biotech Stage (inferred) GrowthCall status No reported sale
Source linked the Form D on EDGAR↗Website verified neuropathix.com↗Named in the filing 1 executive & director

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.